Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP joins Antares

Bruce Freundlich appointed senior VP, medical

Antares Pharma has appointed Dr Bruce Freundlich as senior VP, medical.

Dr Freundlich has extensive experience in both academia and industry, including spells at Merck & Co, Wyeth and Pfizer.

During his time at Pfizer from 2009 to 2010 he served as VP, inflammation. He assumed the role after his previous company Wyeth - where he served as VP - global medical affairs, was taken over by Pfizer.

Most recently, he served as president of New Light Medical Consultants.

Antares Pharma has made several senior appointments in the past year, including a new VP, clinical development, and senior VP, pharma sales and marketing, as the company looks to commercialise Otrexup (methotrexate) for arthritis and advance the development of testosterone replacement therapy Vibex QS T.

“Everyone associated with Antares is excited about his joining the organisation at a time when we are establishing our own commercial presence in the rheumatology field,” said Dr Paul Wotton, CEO of Antares.

Dr Freundlich's experience in rheumatology includes his position as chief of clinical rheumatology at the University of Pennsylvania in the US.

6th November 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...